AtomVie Global Radiopharma

AtomVie Global Radiopharma is a global leading CDMO (Contract Development and Manufacturing Organization) responsible for the development, manufacturing, and global distribution of radiopharmaceuticals. AtomVie provides comprehensive scientific, technical, regulatory, quality, logistics, and commercial expertise, combined with dedicated infrastructure for the development of your radiotherapeutic drugs from Phase I to the commercial market. AtomVie has extensive experience in the manufacturing of radiopharmaceuticals, including expertise in radiolabeling using a range of radioisotopes (such as Lu-177, Ac-225, I-131) and ligands (from small molecules to peptides to small antibodies and large antibodies).